SRRKScholar Rock Holding Corporation Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 22060
Ticker: SRRK
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-05-24
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: SRRK

Detail

Enriched 2026-08-14 20:47

Market cap: $6,554,483,877.24
Shares outstanding (class): 121,785,282
Shares outstanding (weighted): 121,785,282
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 289
Location: CAMBRIDGE, MA
Homepage: https://www.scholarrock.com
Description: Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Market cap and share counts drift.

Funds holding this security

148 funds · 151 positions · $1.10B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$137.02M	0.01%	2,787,327 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$104.72M	0.15%	2,130,120 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$96.45M	1.30%	1,961,965 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$91.60M	0.72%	1,863,285 NS	FIGI
Eventide Gilead Fund MUTUAL FUND SERIES TRUST	—	$71.82M	2.68%	1,460,906 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$67.34M	0.62%	1,369,780 NS	FIGI
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$55.49M	0.07%	1,128,752 NS	FIGI
Hood River Small-Cap Growth Fund Manager Directed Portfolios	—	$52.57M	1.01%	1,069,421 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$46.50M	0.06%	945,796 NS	FIGI
PGIM Jennison Small Company Fund Prudential Jennison Small Co Fund, Inc.	—	$39.80M	1.25%	809,594 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$39.40M	0.48%	801,547 NS	FIGI
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$35.34M	2.23%	718,807 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$32.22M	0.26%	655,394 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$29.19M	0.36%	593,730 NS	FIGI
Loomis Sayles Small Cap Growth Fund LOOMIS SAYLES FUNDS II	—	$17.56M	0.91%	357,197 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERSRRK
FIGI_COMPOSITEBBG00KT2RRM6
FIGI_SHARE_CLASSBBG00KT2RSD4
CIK0001727196
ISINUS80706P1030
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Scholar Rock is a biopharmaceutical company developing therapies, classified under biological products.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.